Pay in 4 interest-free payments of $6.17 Learn more
Ships within 48 hours · Estimated delivery Nov 6 - Nov 11
One of the advanced treatments available to our patients is GLP-1 injections
GLP-1s can go a long way when combined with a healthy diet and regular exercise
In clinical studies, higher levels of circulating long- and medium-chain acylcarnitines showed mixed results in patients with Alzheimers disease [24, 25] whereas clinical trials of patients with Parkinsons disease have consistently shown that circulating levels of long-chain acylcarnitines are decreased [26,27,28]
In previous analyses, we uncovered an intriguing trend: individuals with type 2 diabetes who are initiating treatment of GLP-1 RA therapies are increasingly doing so at lower A1cs and BMIs (Cartwright et al., 2024)
2025 Mar 1;37(1):S61
